Form D · Biotechnology
Beeken BioMedical, LLC
Stoughton, MA · CIK 0001526878
Offering snapshot reported Aug 19, 2020 · SEC filing
- Reported sold
- $6.33M Offering amount: $6.33M
- Investors reported
- 69 Form D · investor count
- Minimum accepted
- $14.2K Reported outside-investor minimum
- First sale
- May 5, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2020 | Initial | $6,330,531 | No comparison | 69 | SEC filing |
| Aug 17, 2020 | Amendment | $2,500,000 | $1,812,538vs Mar 31, 2015 | 19 | SEC filing |
| Mar 31, 2015 | Initial | $687,462 | No comparison | 8 | SEC filing |
| Aug 1, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373526
Source: Form D, filed Aug 19, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Basham | Executive, Promoter |
| Peter Beemsterboer | Director, Executive, Promoter |
| Charles Blixt | Director |
| Richard Kendall | Director, Executive |
| Kendall Richard | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
378 Page Street Suite 201
Stoughton, MA, 02072
Stoughton, MA, 02072